[1] Zhao XH,Huang L.The characteristics of endothelial progenitor cell biology and its effects on the cardiovascular system.Chin J Interven Card.2005; 13(6):405-407.
[2] 范思均,何守志.血管内皮生长因子A的选择性剪接与眼内新生血管的生成[J].中华眼科杂志,2011,47(4):373- 377.
[3] Kawamoto A,Losordo DW.Endothelial progenitor cells for cardiovascular regeneration.Trends Cardiovasc Med.2008;18(1):33-37.
[4] Chade AR,Zhu X,Lavi R,et al.Endothelial progenitor cells restore renal function in chronic experimental renovaseular disease. Circulation. 2009;119(4): 547-557.
[5] Patschan D,Krupineza K,Patschan S,et al.Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia:modulation by ischemic pre. conditioning.Am J Physiol Renal Physiol.2006; 291(1): F176-185.
[6] Lu Y,Gong Y,Lian J,et al.Expansion of Endothelial Progenitor Cells in High Density Dot Culture of Rat Bone Marrow Cells.PLoS One.2014;9(9):e107127.
[7] Ching YH,Sutton TL,Pierpont YN,et al.The use of growth factors and other humeral agents to accelerate and enhance burn wound healing.Eplasty. 2011; 11(e41):429-449.
[8] Bao P, Kodra A, Tomic-Canic M, et al.The role of vascular endothelial growth factor in would healing.J Surg Res.2009;153(2):347-358.
[9] Patschan D,Krupincza K,Patschan S,et al.Dynamics of mobilization and homing of endothelial pmgenitor ceUs after acute renal ischemia:modulation by ischemi. preconditioning.Am J Physiol Renal Physiol. 2006;291: 176-185.
[10] atenaude A,Parker J,Kglsan A.Involvement of endothelial pro-genitor cells in tumor vascularization. Micmvasc Res.2010;79(3):217-223.
[11] Ambms JT,HeⅡ℃m-Fresneda I,Borau 0G,et al. Ischemic preconditioning in solid organ an transplantation: fmm experimental to clinics.Tmnsplant Int.2007;20:219-229.
[12] 蒋素华,邹建洲,刘红,等.通过短时间预缺血改变肾小管上皮细胞命运诱导肾脏缺血耐受[J].中华肾脏病杂志,2011, 27(3):198-202.
[13] Li M, Nishimura H, wakura A,et al.Endothelial pmgenitor cells are rapidly recmited to myocardium and mediate pmtective e bct of ischemic preconditioning via ”imported” nitric oxide synthase activity.Circulation.2005;111(9):1114-1120.
[14] Lee PS,Poh KK.Endothlia progenitor cells in cardiovascular diseases.World J Stem Cells 2014; 6(3):355.
[15] Hu CH,Li ZW,DU ZM,et al.Human umbilical cord- derived endothelial progenitorcells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.Chin Med J(Engl).2009;122(5): 548.
[16] Sambataro M,Seganfreddo E,Canal F,et al.Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.Int J Vasc Med. 2014;2014:589412.
[17] Menne J,Park JK,Shushakova N,et al.Continuous erythropoietin receptor activation affects different pathways of diabetic renal injury.J AIn Soc Nephrol. 2007;18:2046-2053.
[18] Leyland-Jones B,Semiglazov V,Pawlicki M,et al. Maintaining normal hemo-globin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.J Clin Oncol. 2005;23(25):5960-5972.
[19] 陈波,赵卫红,吴剑卿.促红细胞生成素对肺腺癌A549细胞生长和凋亡作用的实验研究[J].中国肺癌杂志,2009, 12(9):956-960.
[20] Bohlius J,Wilson J,Seidenfeld J,et al.Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9 353 patients.J Nati Cancer Inst.2006;98(10):708-714.
[21] 朱蓓,赵卫红,吴剑卿.构建促红细胞生成素表达载体及其在肾小管上皮细胞中的表达[J].中国血液净化,2009, 8(4):211-214.
[22] 麦筱莉,韩 冰,范海健,等.体外标记内皮祖细胞小鼠缺血性脑梗死模型局部移植后向病灶侧迁移的MRI实验研究[J].医学影像学杂志,2015,25(1):143-147.
[23] 康涛,李晓强,盂庆友,等.新型超顺磁性氧化铁标记血管内皮祖细胞的实验研究[J].中国血管外科杂志(电子版), 2012,4(2):108-111.
[24] Liu G,Xia C,Wang Z,et al.Magnetic resonance imaging probes for labeling of chondrocyte cells.J Mater Sci Mater Med.2011;22(3):601-606.
[25] ampetaki A,Kirton JP,Xu Q.Vascular repair by endothelial pro-genitor ceils.Cardiovasc Res. 2008; 78(3):413-421.
[26] Jianguo W,Tianhang L,Hong Z,et al.Optimization of culture conditions for endothelial progenitor cells from porcine bone malTOW in vitro.Cell Pmlif.2010; 43(4): 418-426.
[27] ariucci S,Rovati B,Bencardino K,et al.Flow cytometric detec. tion of circulating endothelial cells and endothelial progenitor cells in healthy subjects.Int J Lab Hematol.2010;32(1 Ptl):e4048.
[28] Estes ML,Mund JA,Mead LE,et al.Application of polychmmatic flow cytometry to identify novel subsets of circulating cells with an-giogenic potential.Cytometry A.2010;77(9):831-839.
[29] Richardson MR,Yoder MC.Endothelial progenitor cells:quo vadis.J Mol Cell Cardiol,2011,50(2):266-272.
[30] Yang N,Li D,Jiao P,et al.The characteristics of endothelial pro-genitor cells derived from mononuclear cells of rat bone marrowin different culture conditions. Cytotechnology.2011;63(3):217-226.
[31] Amsalem Y,Mardor Y,Feinberg MS,et al.Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007;116(11 Suppl):138-145.
[32] Hauger O,Frost EE,van Heeswijk R,et al.MR evaluation of the gIomeruIar homing of magneticalIy labeled mesenchymal stem cells in a rat model of nephropathy.Radiology.2006;238(1):200-210.
[33] Ju SH,Teng GJ.Lu HH,et al.In vivo MR tracking of mesenchymal stem ceils in rat liver after intrasplenic transpIantation.Radiology,2007,245(1):206-215.
[34] Arbab AS,Pandit SD,Anderson SA,et al.Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothellal progenitor ceIIs trafficking to sites of tumor angiogenesis.Stem Cells. 2006;24(3):671-678.
[35] Henning TD,Gawande R,Khurana A,et al.Magnetic resonance imaging of ferumoxide 1abeled mesenchymal stem cells in cartiIage defects: in vitro and in vivo investigations.Mol Imaging. 2012;11(3): 197-209.
[36] Khurana A,Nejadnik H,Gawande R,et al.Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transpIants.Radiology.2012;264(3):803-811.
[37] Khurana A,Chapelin F,Beck G,et al.Iron administration before stem celI harvest enables MR imaging tracking after transplantation.Radiology.2013;269(1):186-197.
[38] Liu W,Frank Jh.Detection and quantification of magnetically la-beled cells by cellularMRI.Eur J Radiol. 2009;70(2):258-264.
[39] Ai H.Layer-by-layer capsules for magnetic resonance imaging and dmg delivery.Adv Drug Deliv Rev.2011; 63(9):772-788. |